NCT03990480View on ClinicalTrials.gov

Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

PHASE4CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

April 1, 2019

Study Completion Date

April 10, 2019

Conditions
Hypertension
Interventions
DRUG

valsartan (160 mg/d)

Group I treated with valsartan (160 mg/d, n = 100)

DRUG

amlodipine (10 mg/d).

Group II amlodipine (10 mg/d, n = 100).

Trial Locations (1)

31527

Tanta University Hospital, Tanta

All Listed Sponsors
collaborator

Tanta University

OTHER

lead

Damanhour University

OTHER

NCT03990480 - Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level | Biotech Hunter | Biotech Hunter